Equities

Servana AB (publ)

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Servana AB (publ)

Actions
  • Price (EUR)0.0002
  • Today's Change0.00 / 0.00%
  • Shares traded800.00k
  • 1 Year change0.00%
  • Beta-0.6284
Data delayed at least 15 minutes, as of Feb 16 2026 08:16 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Servana AB (publ), formerly Medimi AB, is a Sweden-based company operating within healthcare and pharmaceutical industries. The Company develops solutions that provide healthcare recipients and staff with drug management. The business focus is to develop, manufacture and sell products that facilitate patient medication. The products are sold under separate brands and include systems for medication assistance that send alarms at missed doses to relatives or caregivers, and the Company manufactures stationary tablet dispensers. The solution covers the entire chain, from doctors to dispensing at home. The products are at the forefront of technology and are developed for integration into IT environments.

  • Revenue in SEK (TTM)1.35m
  • Net income in SEK-8.31m
  • Incorporated1999
  • Employees5.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SERV:AKT since
announced
Transaction
value
SpellDeal completed09 Jun 202509 Jun 2025Deal completed----
New Equity Venture MidCo III ABAnnounced01 Apr 202501 Apr 2025Announced--866.00k
Data delayed at least 15 minutes, as of Feb 13 2026.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.